Christopher Pasquale Analyst PerformanceSenior Analyst at BarclaysChristopher Pasquale is a stock analyst at Barclays focused in the healthcare sector, covering 23 publicly traded companies. Over the past year, Christopher Pasquale has issued 29 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Christopher Pasquale's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Christopher Pasquale's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings38 Last 9 YearsBuy Recommendations57.89% 22 Buy RatingsCompanies Covered23 Unique Companies Ratings Distribution38RatingsDistribution of strong buy, buy, hold, and sell ratings by Christopher Pasquale.RatingPercentageCount Strong Buy23.7%9 ratings Buy34.2%13 ratings Hold36.8%14 ratings Sell5.3%2 ratingsOut of 38 total stock ratings issued by Christopher Pasquale at Barclays, the majority (36.8%) have been Hold recommendations, followed by 34.2% Buy, 23.7% Strong Buy, and 5.3% Sell.Best & Worst CallsBest Call000.0%BSXApr 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%DXCMApr 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ65.2% of companies on NASDAQ15 companiesNYSE34.8% of companies on NYSE8 companiesChristopher Pasquale, an analyst at Barclays, currently covers 23 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare22 companies95.7%Industrials1 company4.3%Christopher Pasquale of Barclays specializes in stock coverage within the Healthcare sector, with additional focus on Industrials companies.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES21 companies91.3%BIOTECHNOLOGY1 company4.3%PROFESSIONAL SERVICES1 company4.3% Christopher Pasquale's Ratings History at Barclays Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAXGNAxoGen10/23/2026Lower Price Target$36.68$50.00Overweight$0.0000.00% ROIISRGIntuitive Surgical10/21/2026Reiterated Rating$438.00$500.00Overweight$0.0000.00% ROIMMEDMiniMed Group10/7/2026Initiated Coverage$19.64$22.00Equal Weight$0.0000.00% ROISENSSenseonics Holdings, Inc. Common Stock10/7/2026Initiated Coverage$9.96$10.00Equal Weight$0.0000.00% ROITMDXTransMedics Group10/7/2026Initiated Coverage$80.28$120.00Overweight$0.0000.00% ROIALCAlcon10/7/2026Upgrade$62.96Hold$0.0000.00% ROIBLCOBausch + Lomb10/7/2026Upgrade$17.34Strong-Buy$0.0000.00% ROIBSXBoston Scientific10/7/2026Upgrade$41.55Hold$0.0000.00% ROICOOCooper Companies10/7/2026Upgrade$54.75Hold$0.0000.00% ROIDXCMDexCom10/7/2026Upgrade$84.30Strong-Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. EWEdwards Lifesciences10/7/2026Upgrade$85.62Strong-Buy$0.0000.00% ROIGEHCGE HealthCare Technologies10/7/2026Upgrade$64.67Strong-Buy$0.0000.00% ROIHUMAHumacyte10/7/2026Upgrade$0.47Hold$0.0000.00% ROIISRGIntuitive Surgical10/7/2026Upgrade$414.52Strong-Buy$0.0000.00% ROILIVNLivaNova10/7/2026Upgrade$75.93Strong-Buy$0.0000.00% ROIMDTMedtronic10/7/2026Upgrade$85.51Hold$0.0000.00% ROIPODDInsulet10/7/2026Upgrade$134.36Hold$0.0000.00% ROISYKStryker10/7/2026Upgrade$275.17Strong-Buy$0.0000.00% ROITNDMTandem Diabetes Care10/7/2026Upgrade$15.84Hold$0.0000.00% ROIZBHZimmer Biomet10/7/2026Upgrade$88.42Hold$0.0000.00% ROICOOCooper Companies10/6/2026Initiated Coverage$56.43$60.00Positive$0.0000.00% ROIPRCTPROCEPT BioRobotics10/6/2026Initiated Coverage$17.51$30.00Overweight$0.0000.00% ROIMDTMedtronic10/6/2026Initiated Coverage$87.01$95.00Equal Weight$0.0000.00% ROIINSPInspire Medical Systems10/6/2026Initiated Coverage$68.12$65.00Underweight$0.0000.00% ROIBBNXBeta Bionics10/6/2026Initiated Coverage$18.63$30.00Overweight$0.0000.00% ROIBLCOBausch + Lomb10/6/2026Initiated Coverage$17.21$24.00Overweight$0.0000.00% ROIBBNXBeta Bionics10/6/2026Upgrade$17.43Strong-Buy$0.0000.00% ROIINSPInspire Medical Systems10/6/2026Upgrade$66.50Strong Sell$0.0000.00% ROIPRCTPROCEPT BioRobotics10/6/2026Upgrade$17.90Strong-Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenWeiss RatingsUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.